Novel Resistance Mutations to ALK Tyrosine Kinase Inhibition Arising During Cell-Culture Drug Selections in T-Cell Lymphoma

被引：0
|
作者：
Groysman, Matthew [1 ]
Amin, Amit Dipak [1 ]
Tapia, Edgar [1 ]
Rajan, Soumya [1 ]
Schatz, Jonathan [1 ]
机构：
[1] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA
来源：
FASEB JOURNAL | 2015年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
576.1
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma
    Bhawana George
    Suraj Konnath George
    Wenyu Shi
    Abedul Haque
    Ping Shi
    Ghazaleh Eskandari
    Magnus Axelson
    Olle Larsson
    Ahmed O. Kaseb
    Hesham M. Amin
    Journal of Hematology & Oncology, 12
  • [22] Identifying Novel Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Anaplastic Large Cell Lymphoma
    Atabay, Elif
    Wang, Qi
    Chiara, Ambrogio
    Cheong, Taek-Chin
    Peola, Silvia
    Sharma, Geeta G.
    Mologni, Luca
    Gambacorti-Passerini, Carlo
    Voena, Claudia
    Chiarle, Roberto
    BLOOD, 2019, 134
  • [23] Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase
    Mattila, Elina
    Marttila, Heidi
    Sahlberg, Niko
    Kohonen, Pekka
    Tahtinen, Siri
    Halonen, Pasi
    Perala, Merja
    Ivaska, Johanna
    BMC CANCER, 2010, 10
  • [24] Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase
    Elina Mattila
    Heidi Marttila
    Niko Sahlberg
    Pekka Kohonen
    Siri Tähtinen
    Pasi Halonen
    Merja Perälä
    Johanna Ivaska
    BMC Cancer, 10
  • [25] NOVEL MUTATION IN BRUTON'S TYROSINE KINASE IN PATIENT WITH CUTANEOUS T CELL LYMPHOMA
    Humpel, O.
    Kalkat, A.
    Hostoffer, R.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S139 - S139
  • [26] Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib
    Yang, C.
    Lu, P.
    Lee, F. Y.
    Chadburn, A.
    Barrientos, J. C.
    Leonard, J. P.
    Ye, F.
    Zhang, D.
    Knowles, D. M.
    Wang, Y. L.
    LEUKEMIA, 2008, 22 (09) : 1755 - 1766
  • [27] PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma
    Chung, Elaine Y.
    Mai, Yun
    Shah, Urvi A.
    Wei, Yongqiang
    Ishida, Elise
    Kataoka, Keisuke
    Ren, Xiaoxin
    Pradhan, Kith
    Bartholdy, Boris
    Wei, Xiaolei
    Zou, Yiyu
    Zhang, Jinghang
    Ogawa, Seishi
    Steidl, Ulrich
    Zang, Xingxing
    Verma, Amit
    Janakiram, Murali
    Ye, B. Hilda
    CLINICAL CANCER RESEARCH, 2019, 25 (12) : 3589 - 3601
  • [28] Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib
    C Yang
    P Lu
    F Y Lee
    A Chadburn
    J C Barrientos
    J P Leonard
    F Ye
    D Zhang
    D M Knowles
    Y L Wang
    Leukemia, 2008, 22 : 1755 - 1766
  • [29] Novel immunotherapy for adult T-cell leukemia/lymphoma: Targeting aurora kinase A
    Casey, Nicholas Paul
    Fujiwara, Hiroshi
    Ochi, Toshiki
    Yasukawa, Masaki
    OncoImmunology, 2016, 5 (11):
  • [30] AlemtuzumabDevelopment of drug resistance in erythrodermic peripheral T-cell lymphoma: case report
    Reactions Weekly, 2019, 1742 (1) : 19 - 19
12345